Patents by Inventor Jörg Eder

Jörg Eder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Uses of piperidinyl-indole derivatives
    Patent number: 11723901
    Abstract: The present invention relates to the novel use of certain piperidinyl-indole derivatives in the treatment of patients suffering from renal diseases or disorders, and in particular for the treatment of patients suffering from C3G (C3 glomerulopathy) and IgAN (IgA nephropathy).
    Type: Grant
    Filed: August 30, 2018
    Date of Patent: August 15, 2023
    Assignee: Novartis AG
    Inventors: Jörg Eder, Richard Alexander Harrison, Boerje Haraldsson, Anna Svenja Schubart
  • NOVEL USES OF PIPERIDINYL-INDOLE DERIVATIVES
    Publication number: 20200338059
    Abstract: The present invention relates to the novel use of certain piperidinyl-indole derivatives in the treatment of patients suffering from renal diseases or disorders, and in particular for the treatment of patients suffering from C3G (C3 glomerulopathy) and IgAN (IgA nephropathy).
    Type: Application
    Filed: August 30, 2018
    Publication date: October 29, 2020
    Inventors: Jörg EDER, Richard Alexander HARRISON, Boerge HARALDSSON, Anna Svenja SCHUBART
  • 2-aminopyrimidine derivatives and their medical use
    Patent number: 7615562
    Abstract: A compound of formula I or a pharmaceutically acceptable salt, ester or prodrug thereof wherein the variables have the meanings as defined in the specification. Further disclosed are a method of inhibiting IKK activity using a compound of formula I, a method of inhibiting production of TNF using a compound of formula I, a compound of formula I for use as a pharmaceutical, a pharmaceutical composition comprising a compound of formula I, and use of a compound of formula I in the manufacture of a medicament for use as an immunosuppressant or anti-inflammatory agent.
    Type: Grant
    Filed: April 8, 2004
    Date of Patent: November 10, 2009
    Assignee: Novartis AG
    Inventors: Birgit Bollbuck, Alastair DenholmMritain, Jörg Eder, René Hersperger, Philipp Janser, Lászlo Révész, Achim Schlapbach, Rudolf Wálchi